Syneos Health, Inc. Class A SYNH 深 沪
等待开盘 09-03 09:30:00 美东时间
42.98
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 42.98
- 总市值 44.70亿
- 52周最高 52.23
- 市盈率 静 16.69
- 换手率 0.00%
- 52周最低 22.894
- 委 比 0.00%
- 总股本 1.04亿
- 历史最高 104.18
- 量 比 0
- 振 幅 0.00%
- 历史最低 22.894
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering
Synergy CHC Corp. announced the closing of an underwritten public offering of 1.75 million shares at $2.50 per share, raising $4.375 million before expenses. The underwriters have a 45-day option to purchase up to 262,500 additional shares. Warrants for up to 52,500 shares were also issued, with expiration dates spread over three years. Bancroft Capital acted as the sole book-running manager. The shares were offered under a registration statement...
08-27 20:15
Syneos Health’s COGNIKET-MCI Trial: A Promising Step in Cognitive Health Research
Syneos Health (($SYNH)) announced an update on their ongoing clinical study. St...
08-15 00:21
霍尼韦尔(HON.US)分拆之际 Elliott合伙人Steinberg或加入董事会
据报道，在霍尼韦尔(HON.US)准备分拆为三个独立的实体之际，这家工业巨头预计将任命Elliott Investment Management合伙人Marc...
05-28 19:54
Honeywell appoints Elliott partner Marc Steinberg to board amid breakup
Honeywell International (NASDAQ:HON) announced on Wednesday that Marc Steinberg, a partner at Elliott Investment Management, was elected to its board of directors as an independent director and member...
05-28 19:16
HONEYWELL APPOINTS MARC STEINBERG TO BOARD OF DIRECTORS
CHARLOTTE, N.C., May 28, 2025 /PRNewswire/ -- Honeywell (NASDAQ: HON) announced today that its Board of Directors has elected Marc Steinberg, a Partner at Elliott Investment Management, L.P....
05-28 19:00
CorMedix targets $50M-$60M revenue for H1 2025 with DefenCath growth
Earnings Call Insights: CorMedix Inc. (CRMD) Q4 2024 Management View CEO Joe Todisco highlighted the commercial success of DefenCath, noting net revenue of $31.2 million for Q4 and $43.5 million for t...
03-25 22:52
重磅！2025年度全球咨询公司排行榜出炉
来源：四大新鲜事儿 纽约时间2025年2月12日，全球管理咨询行业权威排名机构Vault正式发布2025年度全球咨询公司排行榜，包括2025年北美、欧洲...
02-21 13:05
CytoDyn Phase 2 study of leronlimab cleared by FDA
CytoDyn (OTCQB:CYDY) said the FDA has cleared a Phase 2 study of its drug leronlimab for the treatment of relapsed/refractory microsatellite stable colorectal cancer. Patient enrollment for the study ...
2024-11-04 23:22
交易估值不断攀升 肿瘤领域合作占比四成 ——2023年全球医药市场交易情况回顾
2023年，生命科学领域的交易活动继续放缓。在全球宏观经济动荡、通胀上升、监管审查严格等因素影响下，这一年的收并购、授权许可以及合作研发交易达成遇阻。根据IQ...
2024-07-05 09:32
Veeva Vault EDC Überschreitet Den Meilenstein Von 1.000 Studienstarts
Acht der 20 größten Biopharmaunternehmen setzen auf Vault EDC, um eine moderne...
2024-03-21 01:54
